A call for an industry-led initiative to critically assess machine learning for real-world drug discovery
Other text in scientific journal, 2024
No abstract available
Author
Cas Wognum
Recursion Pharmaceuticals
Valence Labs
Jeremy R. Ash
Johnson & Johnson Innovative Medicine
Matteo Aldeghi
Bayer Research and Innovation Center
Raquel Rodríguez-Pérez
Novartis International AG
Cheng Fang
Blueprint Medicines Corporation
Alan C. Cheng
Merck & Co., Inc.
Daniel J. Price
Nimbus Therapeutics
Djork Arné Clevert
Pfizer
Ola Engkvist
Chalmers, Computer Science and Engineering (Chalmers)
AstraZeneca AB
W. Patrick Walters
Relay Therapeutics
Nature Machine Intelligence
25225839 (eISSN)
Vol. 6 10 1120-1121Subject Categories
Computer Science
DOI
10.1038/s42256-024-00911-w